- Home
- MUFG vs BSX Comparison
MUFG vs BSX Comparison
Compare MUFG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUFG
- BSX
- Stock Information
- Founded
- MUFG 1880
- BSX 1979
- Country
- MUFG Japan
- BSX United States
- Employees
- MUFG N/A
- BSX N/A
- Industry
- MUFG Commercial Banks
- BSX Medical/Dental Instruments
- Sector
- MUFG Finance
- BSX Health Care
- Exchange
- MUFG Nasdaq
- BSX Nasdaq
- Market Cap
- MUFG 137.1B
- BSX 129.7B
- IPO Year
- MUFG 2001
- BSX 1992
- Fundamental
- Price
- MUFG $12.06
- BSX $98.65
- Analyst Decision
- MUFG
- BSX Strong Buy
- Analyst Count
- MUFG 0
- BSX 23
- Target Price
- MUFG N/A
- BSX $96.41
- AVG Volume (30 Days)
- MUFG 2.8M
- BSX 5.3M
- Earning Date
- MUFG 02-04-2025
- BSX 02-05-2025
- Dividend Yield
- MUFG 1.05%
- BSX N/A
- EPS Growth
- MUFG 31.28
- BSX 47.19
- EPS
- MUFG 0.98
- BSX 1.21
- Revenue
- MUFG $40,888,103,933.00
- BSX $15,911,000,000.00
- Revenue This Year
- MUFG N/A
- BSX $17.70
- Revenue Next Year
- MUFG $6.20
- BSX $13.00
- P/E Ratio
- MUFG $11.97
- BSX $81.61
- Revenue Growth
- MUFG 43.87
- BSX 15.66
- 52 Week Low
- MUFG $8.73
- BSX $59.85
- 52 Week High
- MUFG $12.31
- BSX $99.14
- Technical
- Relative Strength Index (RSI)
- MUFG 56.46
- BSX 75.24
- Support Level
- MUFG $11.73
- BSX $93.20
- Resistance Level
- MUFG $12.25
- BSX $97.13
- Average True Range (ATR)
- MUFG 0.15
- BSX 1.55
- MACD
- MUFG 0.03
- BSX 0.73
- Stochastic Oscillator
- MUFG 71.32
- BSX 95.26
About MUFG Mitsubishi UFJ Financial Group Inc.
Mitsubishi UFJ Financial Group is the largest bank in Japan in terms of market capitalization and assets, with an 8.0% share of all domestic loans as of March 2024. It is the largest non-Chinese bank group globally and has a balance sheet slightly larger than those of JPMorgan Chase and HSBC Holdings. MUFG's operations in Japan account for around half of profit, banking in Thailand and Indonesia for around 15%, and equity-method earnings from Morgan Stanley most of the rest.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.